Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TRPM3 | SNV | Missense_Mutation | novel | c.3574C>A | p.His1192Asn | p.H1192N | Q9HCF6 | protein_coding | deleterious(0.01) | probably_damaging(0.974) | TCGA-A2-A0EP-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | CR |
TRPM3 | SNV | Missense_Mutation | | c.1025A>G | p.Asn342Ser | p.N342S | Q9HCF6 | protein_coding | tolerated(0.11) | benign(0.087) | TCGA-A7-A13D-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD |
TRPM3 | SNV | Missense_Mutation | | c.850G>T | p.Val284Phe | p.V284F | Q9HCF6 | protein_coding | deleterious(0) | probably_damaging(0.923) | TCGA-A8-A09T-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | anastrozole | SD |
TRPM3 | SNV | Missense_Mutation | | c.4956N>C | p.Lys1652Asn | p.K1652N | Q9HCF6 | protein_coding | tolerated_low_confidence(0.15) | benign(0.127) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
TRPM3 | SNV | Missense_Mutation | | c.427N>C | p.Glu143Gln | p.E143Q | Q9HCF6 | protein_coding | deleterious(0.01) | possibly_damaging(0.596) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
TRPM3 | SNV | Missense_Mutation | | c.154N>T | p.Leu52Phe | p.L52F | Q9HCF6 | protein_coding | tolerated_low_confidence(0.05) | probably_damaging(0.986) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
TRPM3 | SNV | Missense_Mutation | novel | c.55G>A | p.Glu19Lys | p.E19K | | protein_coding | tolerated_low_confidence(0.09) | benign(0) | TCGA-AC-A5XS-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | femara | SD |
TRPM3 | SNV | Missense_Mutation | novel | c.2600N>G | p.Asn867Ser | p.N867S | Q9HCF6 | protein_coding | tolerated(0.14) | benign(0.143) | TCGA-AC-A6IW-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TRPM3 | SNV | Missense_Mutation | rs764791547 | c.3869C>T | p.Thr1290Met | p.T1290M | Q9HCF6 | protein_coding | deleterious(0.04) | possibly_damaging(0.831) | TCGA-AO-A128-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
TRPM3 | SNV | Missense_Mutation | novel | c.4753G>A | p.Glu1585Lys | p.E1585K | Q9HCF6 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.987) | TCGA-BH-A5J0-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
80036 | TRPM3 | ION CHANNEL, DRUGGABLE GENOME | activator | 53801018 | SPHINGOSINE | |
80036 | TRPM3 | ION CHANNEL, DRUGGABLE GENOME | activator | 178101107 | | |
80036 | TRPM3 | ION CHANNEL, DRUGGABLE GENOME | blocker | 135650927 | ROSIGLITAZONE | |
80036 | TRPM3 | ION CHANNEL, DRUGGABLE GENOME | inhibitor | 135649695 | | |
80036 | TRPM3 | ION CHANNEL, DRUGGABLE GENOME | activator | 381744978 | | |
80036 | TRPM3 | ION CHANNEL, DRUGGABLE GENOME | blocker | 135650566 | MAPROTILINE | |
80036 | TRPM3 | ION CHANNEL, DRUGGABLE GENOME | activator | 135650729 | | |
80036 | TRPM3 | ION CHANNEL, DRUGGABLE GENOME | blocker | 135650829 | PIOGLITAZONE | |
80036 | TRPM3 | ION CHANNEL, DRUGGABLE GENOME | blocker | 135652743 | | |
80036 | TRPM3 | ION CHANNEL, DRUGGABLE GENOME | blocker | 135650177 | DICLOFENAC | |